Neuronetics gets FDA approval for wider use of its NeuroStar treatment system

Malvern-based medical technology company Neuronetics has received Food and Drug Administration clearance to market its NeuroStar treatment system as an adjunct therapy for treating adult patients suffering from obsessive-compulsive disorder. The system, which delivers transcranial magnetic stimulation (TMS) to the brain, is already cleared as a therapy for major depressive disorder. It uses highly focused MRI-strength magnetic field pulses to activate cortical and deep brain structures known to…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news